Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor

Overview of attention for article published in Frontiers in Pharmacology, March 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 75,349 followers.

RT @cpa61: Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor https://t.co/41oNThLJpl https://t.co/iEhJK4AjMC

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor https://t.co/zDXE5N7YqH https://t.co/SP6my3hLVR

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor https://t.co/ZsaMuxqm42 https://t.co/pCYIz8Iiao

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor https://t.co/39z6cFbRfm https://t.co/EKrQOKjx8q

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.